Dynamic interplay between the neutral glycosphingolipid CD77/Gb3 and the therapeutic antibody target CD20 within the lipid bilayer of model B lymphoma cells

Biochemical and Biophysical Research Communications

Volumn 355, Issue 4, 2007, Pages 944-949

  Jarvis, Rosemary M ^a   Chamba, Anita ^b   Holder, Michelle J ^b   Challa, Anita ^b   Smith, Daniel C ^a   Hodgkin, Matthew N ^a   Lord, J Michael ^a   Gordon, John ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Burkitt's lymphoma; CD20; Gb3; Membrane rafts; Shiga like toxin

Indexed keywords

CD20 ANTIBODY; CD27 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CHOLERA TOXIN B SUBUNIT; CHOLESTEROL; COMPLEMENT COMPONENT C3D RECEPTOR; GLOBOTRIAOSYLCERAMIDE; GLYCOSPHINGOLIPID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VEROTOXIN;

ANIMAL CELL; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; DRUG TARGETING; LIGAND BINDING; LIPID BILAYER; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL;

ANTIBODIES; ANTIGENS, CD20; APOPTOSIS; BIOLOGICAL MARKERS; BURKITT LYMPHOMA; CELL LINE, TUMOR; CHOLERA TOXIN; HUMANS; LIPID BILAYERS; MEMBRANE MICRODOMAINS; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS C-BCL-2; SHIGA TOXINS; TRIHEXOSYLCERAMIDES;

EID: 33847611038     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.02.053     Document Type: Article

References (36)

1. Nudelman E., Kannagi R., Hakomori S., Lipinski M., Wiels J., Parsons M., and Tursz T. A Burkitt lymphoma associated glycolipid antigen defined by a monoclonal antibody. Science 220 (1983) 509-511
2. Gregory C.D., Tursz T., Edwards C.F., Tetaud C., Talbot M., Caillou B., Rickinson A., and Lipinski M. Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. Journal of Immunology 139 (1987) 313-318
3. 3/CD77, a glycolipid antigen. Cancer Research 53 (1993) 5314-5319
4. Khine A.A., Tam P., Nutikka A., and Lingwood C.A. Brefeldin A and filipin distinguish two globotriaosyl ceramide/verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity. Glycobiology 14 (2004) 701-712
5. Farkas-Himsley H., Hill R., Rosen B., Arab S., and Lingwood C.A. The bacterial colicin active against tumour cells in vitro and in vivo is verotoxin 1. Proceedings of the National Academy of Science 92 (1995) 6996-7000
6. 3) expression in human tumour cells: intracellular trafficking defines a new retrograde transport pathway from the cell surface to the nucleus, which correlates with sensitivity to verotoxin. Acta Biochimica Polonica 45 (1998) 351-359
7. Fritsch L., Marechal V., Schneider V., Barthet C., Rozenbaum W., Moisan-Coppey M., Coppey J., and Nicholas J. Production of HIV-1 by human B cells infected in vitro: characterization of an EBV genome-negative B cell line chronically synthesising a low level of HIV-1 after infection. Virology 244 (1998) 542-551
8. Karmali M.A., Steele B.T., Petric M., and Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1 (1983) 619-620
9. Riley L.W., Remis R.S., Helgerson S.D., McGee H.B., Wells J.G., Davis B.R., Hebert R.J., Olcott E.S., Johnson L.M., Hargrett N.T., Blake P.A., and Cohen M.L. Hemorrhagic colitis associated with a rare Escherichia coli serotype. New England Journal of Medicine 308 (1983) 681-685
10. Jacewicz M., Clausen H., Nudelman E., Donohue-Rolfe A., and Keusch G.T. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. Journal of Experimental Medicine 163 (1986) 1391-1404
11. Donohue-Rolfe A., Keusch G.T., Edson C., Thorley-Lawson D., and Jacewicz M. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies. Journal of Experimental Medicine 160 (1984) 1767-1781
12. 3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating Lyn kinase activity in human B cells. Experimental Haematology 28 (2000) 1260-1268
13. Holder M., Chamba A., Hardie D.L., Deans J.P., and Gordon J. Improved access to CD20 following B cell receptor cross-linking at Burkitt's lymphoma cell surfaces. Leukaemia Research 28 (2004) 1197-1202
14. Brown D., and Rose J. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68 (1992) 533-544
15. Gordon J., Challa A., Levens J.M., Gregory C.D., Williams J.M., Armitage R.J., Cook J.P., M Roberts L., and Lord J.M. CD40 ligand, Bcl-2, and Bcl-XL spare group I Burkitt lymphoma cells from CD77-directed killing via verotoxins-1 B chain but fail to protect against the holotoxin. Cell Death and Differentiation 7 (2000) 785-794
16. Traulle C., and Coiffier B. Evolving role of rituximab in the treatment of patients with non-Hodgkin's lymphoma. Future Oncology 1 (2005) 297-306
17. Serafeim A., Grafton G., Chamba A., Gregory C.D., Blakely R.D., Bowery N.G., Barnes N.M., and Gordon J. 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors. Blood 99 (2002) 2545-2553
18. Cheng P.C., Dykstra M.L., Mitchell R.N., and Pierce S.K. A role for lipid rafts in B cell antigen receptor signalling and antigen targeting. Journal of Experimental Medicine 190 (1999) 1549-1560
19. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology 37 (1959) 911-917
20. Calderwood S.B., Acheson D.W.K., Goldberg M.B., Boyko S.A., and Donohue-Rolfe A. A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin 1 B subunit. Infection and Immunity 58 (1990) 2977-2982
21. Dive C., Gregory C.D., Phipps D.J., Evans D.L., Milner A.E., and Wyllie A.H. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochimica et Biophsica Acta 1133 (1992) 275-285
22. Green D.R., and Reed J.C. Mitochondria and Apoptosis. Science 281 (1998) 1309-1312
23. Petit P.X., Lecoeur H., Zorn E., Dauguet C., Mignotte B., and Gougeon M. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. Journal of Cell Biology 130 (1995) 157-167
24. Manes S., del Real G., Lacalle R., Lucas P., Gomez-Mouton G., Sanchez-Palomino S., Delgado R., Alcami J., Mira E., and Martinez C. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Reports 1 (2000) 190-196
25. Maloney M.D., and Lingwood C. CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxins B-subunits: implications of molecular mimicry for B cell adhesion and enterohaemorrhagic Escherichia coli pathogenesis. Journal of Experimental Medicine 180 (1994) 191-201
26. Puri A., Hug P., Jernigan K., Barchi J., Kim H., Hamilton J., Wiels J., Murray G.J., Brady R.O., and Blumenthal R. The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilising HIV type 1 envelope glycoprotein. Proceedings of the National Academy of Science 95 (1998) 14435-14440
27. Li H., Ayer L.M., Polyak M.J., Mutch C.M., Petrie R.J., Gauthier L., Shariat N., Hendzel M.J., Shaw A.R., Patel K.D., and Deans J.P. The CD20 calcium channel is localized to microvilli and constitutively associated with membrane rafts: antibody binding increases the affinity of the association through an epitope-dependent cross-linking-independent mechanism. Journal of Biological Chemistry 279 (2004) 19893-19901
28. Falguieres T., Mallard F., Baron C., Hanau D., Lingwood C., Goud B., Salamero J., and Johannes L. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent resistant membranes. Molecular Biology of the Cell 12 (2001) 2453-2468
29. Fujinaga Y., Wolf A., Rodighiero C., Wheeler H., Tsai B., Allen L., Jobling M., Rapoport T., Holmes R., and Lencer W. Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to endoplasmic reticulum. Molecular Biology of the Cell 14 (2003) 4783-4793
30. Brown D., and London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. Journal of Biological Chemistry 275 (2000) 17221-17224
31. 3/CD77) in low density, detergent-insoluble microdomains. Journal of Biological Chemistry 274 (1999) 35278-35282
32. Deans J., Robbins S., Polyak M., and Savage J. Rapid redistribution of CD20 to a low density detergent-insoluble membrane compartment. Journal of Biological Chemistry 273 (1998) 344-348
33. Li H., Ayer L.M., Lytton J., and Deans J.P. Store-operated calcium entry mediated by CD20 in membrane rafts. Journal of Biological Chemistry 278 (2003) 42427-42434
34. Vyas K.A., Patel H.V., Vyas A.A., and Schnaar R.L. Segregation of gangliosides GM1 and GD3 on cell membranes, isolated membrane rafts, and defined supported lipid monolayers. Biological Chemistry 382 (2001) 241-250
35. Burger K., Gimpl G., and Fahrenholz F. Regulation of receptor function by cholesterol. Cellular and Molecular Life Sciences 57 (2000) 1577-1592
36. Chark D., Nutikka A., Trusevych N., Kuzmina J., and Lingwood C. Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody. European Journal of Biochemistry 271 (2004) 405-417